CoChat

Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N‐glycan branching and sialylation

Yin, Bojiao, Gao, Yuan, Chung, Cheng‐yu, Yang, Shuang, Blake, Emily, Stuczynski, Mark C., Tang, Juechun, Kildegaard, Helene F., Andersen, Mikael R., Zhang, Hui, Betenbaugh, Michael J. · 2015 · Biotechnology and Bioengineering
Cited by 84

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Sialic acid, a terminal residue on complex N‐glycans, and branching or antennarity can play key roles in both the biological activity and circulatory lifetime of recombinant glycoproteins of therapeutic interest. In order to examine the impact of glycosyltransferase expression on the N‐glycosylation of recombinant erythropoietin (rEPO), a human α2,6‐sialyltransferase (ST6Gal1) was expressed in Chinese hamster ovary (CHO‐K1) cells. Sialylation increased on both EPO and CHO cellular proteins as observed by SNA lectin analysis, and HPLC profiling revealed that the sialic acid content of total glycans on EPO increased by 26%. The increase in sialic acid content was further verified by detailed profiling of the N‐glycan structures using mass spectra (MS) analysis. In order to enhance antennarity/branching, UDP‐N‐acetylglucosamine: α‐1,3‐D‐mannoside β1,4‐N‐acetylglucosaminyltransferase (GnTIV/Mgat4) and UDP‐N‐acetylglucosamine:α‐1,6‐D‐mannoside β1,6‐N‐acetylglucosaminyltransferase (GnTV/Mgat5), was incorporated into CHO‐K1 together with ST6Gal1. Tri‐ and tetraantennary N‐glycans represented approximately 92% of the total N‐glycans on the resulting EPO as measured using MS analysis. Furthermore, sialic acid content of rEPO from these engineered cells was increased ∼45% higher with tetra‐sialylation accounting for ∼10% of total sugar chains compared to ∼3% for the wild‐type parental CHO‐K1. In this way, coordinated overexpression of these three glycosyltransferases for the first time in model CHO‐K1 cell lines provides a mean for enhancing both N‐glycan branching complexity and sialylation with opportunities to generate tailored complex N‐glycan structures on therapeutic glycoproteins in the future. Biotechnol. Bioeng. 2015;112: 2343–2351. © 2015 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bit.25650

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 84

Metadata

Authors
Yin, B., Gao, Y., Chung, C., Yang, S., Blake, E., Stuczynski, M. C., Tang, J., Kildegaard, H. F., Andersen, M. R., Zhang, H., & Betenbaugh, M. J.
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2015-07-07
Volume
112
Issue
11
Pages
2343-2351
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W2128015484
Cited by
84
References
6
FWCI
5.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N‐glycan branching and sialylation. https://app.cochat.ai/papers/10.1002/bit.25650
The paper
Yin, B., Gao, Y., Chung, C., Yang, S., Blake, E., Stuczynski, M. C., Tang, J., Kildegaard, H. F., Andersen, M. R., Zhang, H., & Betenbaugh, M. J. (2015). Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N‐glycan branching and sialylation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.25650

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.